Blistering severe cutaneous adverse reactions in children: proposal for paediatric-focused clinical criteria

M L Ramien^{1

2

3}, A Bahubeshi³, I Lara-Corrales⁴, E Pope⁴, M L Levy^{5

6}, A J Nopper⁷, N H Shear⁸, L Eichenfield^{9

10}

Affiliations

¹ Division of Community Pediatrics, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
² Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
³ University of Ottawa, Ottawa, ON, Canada.
⁴ Section of Paediatric Dermatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
⁵ Department of Pediatrics and Medicine (Dermatology), Dell Medical School, University of Texas, Austin, TX, USA.
⁶ Pediatric/Adolescent Dermatology, Dell Children's Medical Center, Austin, TX, USA.
⁷ Division of Dermatology, Children's Mercy-Kansas City, Kansas City, MO, USA.
⁸ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁹ Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, CA, USA.
¹⁰ Departments of Dermatology and Pediatrics, University of California, San Diego School of Medicine, University of California, San Diego, CA, USA.

M L Ramien et al. Br J Dermatol. 2021 Aug.

. 2021 Aug;185(2):447-449.

doi: 10.1111/bjd.20063. Epub 2021 May 31.

M L Ramien^{1

2

3}, A Bahubeshi³, I Lara-Corrales⁴, E Pope⁴, M L Levy^{5

6}, A J Nopper⁷, N H Shear⁸, L Eichenfield^{9

10}

¹ Division of Community Pediatrics, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
² Division of Dermatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
³ University of Ottawa, Ottawa, ON, Canada.
⁴ Section of Paediatric Dermatology, The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.
⁵ Department of Pediatrics and Medicine (Dermatology), Dell Medical School, University of Texas, Austin, TX, USA.
⁶ Pediatric/Adolescent Dermatology, Dell Children's Medical Center, Austin, TX, USA.
⁷ Division of Dermatology, Children's Mercy-Kansas City, Kansas City, MO, USA.
⁸ Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁹ Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, CA, USA.
¹⁰ Departments of Dermatology and Pediatrics, University of California, San Diego School of Medicine, University of California, San Diego, CA, USA.

No abstract available

References

1. Hebra F. On Diseases of the Skin, Including the Exanthemata. London: New Syndenham Society, 1866.
1. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Dermatol 1983; 8:763-75.
1. Thomas BA. The so-called Stevens-Johnson syndrome. Br Med J 1950; 1:1393-7.
1. Bastuji-Garin S, Rzany B, Stern RS et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129:92-6.
1. Canavan TN, Mathes EF, Frieden I, Shinkai K. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol 2015; 72:239-45.